MG
ZLAB icon

Michael Gelband’s Zai Lab ZLAB Stock Holding History

Michael Gelband’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,618
Closed -$240K – 2174
2025
Q4 		$240K Buy
+13,618
New +$319K ﹤0.01% 1359
2023
Q4 		– Sell
-144,838
Closed -$3.52M – 2132
2023
Q3 		$3.52M Buy
144,838
+87,640
+153% +$2.33M 0.03% 471
2023
Q2 		$1.59M Buy
+57,198
New +$1.87M 0.01% 908
2021
Q4 		– Sell
-2,053
Closed -$216K – 2673
2021
Q3 		$216K Buy
2,053
+45
+2% +$6.46K ﹤0.01% 1756
2021
Q2 		$355K Buy
+2,008
New +$323K ﹤0.01% 1638
2020
Q4 		– Sell
-11,554
Closed -$961K – 2447
2020
Q3 		$961K Buy
+11,554
New +$928K 0.02% 698
2020
Q1 		– Sell
-238,463
Closed -$9.92M – 1713
2019
Q4 		$9.92M Buy
238,463
+91,491
+62% +$3.38M 0.19% 90
2019
Q3 		$4.75M Buy
146,972
+137,663
+1,479% +$4.72M 0.17% 119
2019
Q2 		$325K Buy
+9,309
New +$274K 0.01% 657

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Michael Gelband's ZLAB Position: Q1 2026 in Review

Michael Gelband sold out of Zai Lab (ZLAB) in Q1 2026, closing a stake of 13,618 shares — an estimated $240K sold.

Michael Gelband first reported a position in ZLAB in Q2 2019 and held it in 9 quarters. The position peaked at $9.92M in Q4 2019. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • Michael Gelband reported no remaining Zai Lab position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 13,618 Zai Lab shares in Q1 2026, an estimated $240K.
  • Michael Gelband first reported a position in Zai Lab in Q2 2019 and held it in 9 quarters.
  • Michael Gelband's Zai Lab position peaked at $9.92M in Q4 2019.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.